FDA Inspection 1231434 — Agrex, Inc.

Agrex, Inc. — FEI 3007853939

The FDA completed an inspection of Agrex, Inc. on Mar 20, 2024 in Minneapolis, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 20, 2024
Fiscal Year
2024
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Minneapolis, MN (United States)

Additional Details

FSVP

Citations

IDCFRDescription
1825421 CFR 1.502(a)Develop FSVP
1832821 CFR 1.509(a)Identification - entry

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.